Support Alert

Class 4 medicines defect information: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe

Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) has informed the Medicines and Healthcare products Regulatory Agency (MHRA) of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage of the needle.


Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society

Loading...